This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits

California-based Foresite Capital Management VI fully exited Edgewise Therapeutics (NASDAQ:EWTX) in the quarter ended September 30, reducing its position by 585,000 shares worth about $7.67 million.According to a filing with the U.S. Securities and Exchange Commission dated November 14, Foresite Capital Management VI LLC sold its entire stake in Edgewise Therapeutics (NASDAQ:EWTX) during the third quarter. The trade amounted to an estimated $7.67 million based on quarterly average pricing, and the fund reported no remaining shares in the company as of September 30.Edgewise Therapeutics was previously about 4.3% of AUM in the prior quarter.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool